Table 1. Baseline characteristics of the patients.
| Characteristic | Values | |
|---|---|---|
| Age (yr) | 56 (18–87) | |
| ≤56 | 119 (52) | |
| >56 | 10 (48) | |
| Menopausal status | ||
| Premenopausal | 66 (28.8) | |
| Postmenopausal | 163 (71.2) | |
| Grade | ||
| 2 | 51 (22.3) | |
| 3 | 178 (77.7) | |
| Tumor size (cm) | 12 (4–40) | |
| <12 | 133 (58.1) | |
| ≥12 | 96 (41.9) | |
| Ascites | ||
| Present | 171 (74.7) | |
| Absent | 58 (25.3) | |
| Peritoneal cytology | ||
| Positive | 186 (81.2) | |
| Negative | 43 (18.8) | |
| LNs removed | 63 (32–132) | |
| Pelvic LNs | 36 (20–79) | |
| Para-aortic LNs | 23 (10–85) | |
| Positive LNs | 5 (1–89) | |
| Pelvic LNs | 2 (0–50) | |
| Para-aortic LNs | 3 (0–46) | |
| LNR (%) | 8.4 (0.9–90.4) | |
| <10 | 120 (52.4) | |
| 10–49 | 81 (35.4) | |
| ≥50 | 28 (12.5) | |
| FIGO stage | ||
| IIIA1 | 31 (13.6) | |
| IIIB | 15 (6.6) | |
| IIIC | 183 (79.9) | |
| Cytoreduction | ||
| Maximal | 144 (62.9) | |
| Optimal | 85 (37.1) | |
| Status | ||
| Alive | 143 (62.4) | |
| Dead | 86 (37.6) | |
Values are presented as number (median) or number (%).
FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node; LNR, lymph node ratio.